Inotiv leverages the latest technologies, including advanced molecular assays and next-generation in vitro and in vivo models, to uncover crucial insights into infectious agents. Whether it’s identifying novel pathogens or understanding resistance mechanisms, our comprehensive approach ensures thorough investigations that drive meaningful results.

With a focus on a multi-disciplinary approach to drug discovery and development and a dedication to scientific rigor, our team of experts harnesses the latest technologies and methodologies to explore the intricate mechanisms underlying infectious diseases. Whether you're seeking preclinical testing, biomarker analysis, or mechanistic studies, Inotiv is your trusted partner every step of the way.